Macrogenics Inc
3 known investors
MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients, including oncology, hematology, and autoimmune applications. The company uses platform technologies such as antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.